lobbying_activities: 1656550

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1656550	5cbe6e82-debd-4304-81de-17f268c9005e	Q1	STANTON PARK GROUP	83717	SHIRE PHARMACEUTICALS LLC	2015	first_quarter	HCR	access to rare and orphan disease therapeutics; newborn screening for heritable disorders; H.R. 909, Andrea Sloan Compassionate Use Reform and Enhancement Act, relating to expanded access; 21st Century Cures initiative	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2015-04-06T16:46:53.863000-04:00